These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 6547813
21. The pulmonary disposition of theophylline and its influence on human alveolar macrophage bactericidal function. O'Neill SJ, Sitar DS, Klass DJ, Taraska VA, Kepron W, Mitenko PA. Am Rev Respir Dis; 1986 Dec; 134(6):1225-8. PubMed ID: 3789521 [Abstract] [Full Text] [Related]
22. Catabolism of rat surfactant disaturated phosphatidylcholines during incubation of alveolar lavage materials in vitro at 37 degrees C. Miles PR, Castranova V, Bowman L. Biochim Biophys Acta; 1985 Aug 22; 836(1):39-44. PubMed ID: 3839685 [Abstract] [Full Text] [Related]
23. Activities of human alveolar macrophages (HAMs). Note 1: Observations on phagocytosis and bacterial killing in the presence of miocamycin. Capelli A, Capelli O, Azzolini L, Richeldi L, Prandi E, Velluti G. Chemioterapia; 1988 Apr 22; 7(2):89-95. PubMed ID: 3260827 [Abstract] [Full Text] [Related]
24. Inability to sustain intraphagolysosomal killing of Staphylococcus aureus predisposes to bacterial persistence in macrophages. Jubrail J, Morris P, Bewley MA, Stoneham S, Johnston SA, Foster SJ, Peden AA, Read RC, Marriott HM, Dockrell DH. Cell Microbiol; 2016 Jan 22; 18(1):80-96. PubMed ID: 26248337 [Abstract] [Full Text] [Related]
25. Lung surfactant protein A (SP-A) activates a phosphoinositide/calcium signaling pathway in alveolar macrophages. Ohmer-Schröck D, Schlatterer C, Plattner H, Schlepper-Schäfer J. J Cell Sci; 1995 Dec 22; 108 ( Pt 12)():3695-702. PubMed ID: 8719876 [Abstract] [Full Text] [Related]
26. Influence of modified natural and synthetic surfactant preparations on bacterial killing by polymorphonuclear leucocytes. Rauprich P, Walter G, Jarstrand C, Robertson B, Herting E. Immunobiology; 2004 Dec 22; 209(8):609-17. PubMed ID: 15638129 [Abstract] [Full Text] [Related]
27. Human alveolar lining material and antibacterial defenses. Jonsson S, Musher DM, Goree A, Lawrence EC. Am Rev Respir Dis; 1986 Jan 22; 133(1):136-40. PubMed ID: 3484618 [Abstract] [Full Text] [Related]
28. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS. J Immunol; 1995 Dec 01; 155(11):5343-51. PubMed ID: 7594549 [Abstract] [Full Text] [Related]
31. Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia. Jakab GJ. Am Rev Respir Dis; 1982 Nov 01; 126(5):778-82. PubMed ID: 7149441 [Abstract] [Full Text] [Related]
32. Effects of Histoplasma capsulatum products on the functional activity of alveolar macrophages. Carvajal RE, Hernandez-Mendoza L, Maldonado G. Eur J Respir Dis; 1986 Jul 01; 69(1):36-45. PubMed ID: 3743687 [Abstract] [Full Text] [Related]
33. Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 2. Chemotaxis and phagocytosis of 3H-Staphylococcus aureus by human macrophages. Carlone NA, Cufini AM, Tullio V, Sassella D. Microbios; 1989 Jul 01; 58(234):17-25. PubMed ID: 2739586 [Abstract] [Full Text] [Related]
35. Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs. Jakab GJ, Green GM. J Clin Invest; 1976 Jun 01; 57(6):1533-9. PubMed ID: 180054 [Abstract] [Full Text] [Related]
37. Staphylococcal clearance and pulmonary macrophage function during influenza infection. Nugent KM, Pesanti EL. Infect Immun; 1982 Dec 01; 38(3):1256-62. PubMed ID: 7152668 [Abstract] [Full Text] [Related]